NCT03277469 2026-04-22
Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer
Brigham and Women's Hospital
Phase NA Active not recruiting
Clinical Trials
94 trialsNCT07061977 2026-04-22
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
NCT03634267 2026-04-15
MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT02466971 2026-04-13
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT05570422 2026-04-08
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
Kortuc, Inc.
Phase 1 Recruiting
NCT02865837 2026-03-27
VESICOL
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT07276360 2026-03-27
HypoRTCx-UG
Uganda Cancer Institute
Phase 2 Recruiting
NCT03315351 2026-03-13
TEP-Curie
Centre Oscar Lambret
Phase NA Completed
NCT03256916 2026-02-24
NELCER
Tata Memorial Hospital
Phase 3 Completed
NCT04221945 2026-02-20
KEYNOTE-A18
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03955978 2026-01-06
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
Washington University School of Medicine
Phase 1 Active not recruiting
NCT06331468 2025-12-26
Hypofractionated Radiochemotherapy
University of Kentucky
Phase 2 Recruiting
NCT03422198 2025-12-12
SAVE
University of Utah
Phase 3 Recruiting
NCT07232654 2025-12-01
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT02595879 2025-11-13
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT03738228 2025-11-12
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT06543576 2025-08-15
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
Jonsson Comprehensive Cancer Center
Phase 1/2 Recruiting
NCT07121543 2025-08-13
Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy
University of California, San Diego
Recruiting
NCT02635360 2025-07-03
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
University of Virginia
Phase 2 Completed
NCT04634877 2025-06-09
KEYNOTE-B21
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT05994300 2025-06-08
Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer
Peking Union Medical College Hospital
Phase NA Active not recruiting
NCT05857631 2025-04-15
PARCERII
Tata Memorial Centre
Phase NA Recruiting
NCT06882473 2025-03-18
A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer
Peking University Third Hospital
Phase NA Not yet recruiting
NCT06752135 2024-12-30
HRCC1
Azienda Policlinico Umberto I
Terminated
NCT06288373 2024-10-30
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
Tongji Hospital
Phase 2/3 Recruiting
NCT03830866 2024-07-26
CALLA
AstraZeneca
Phase 3 Completed
NCT06419673 2024-05-17
Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
NCT06333821 2024-03-27
A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma
Biotech Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
NCT05173272 2023-12-27
Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer
Sichuan Cancer Hospital and Research Institute
Phase 3 Recruiting
NCT01041027 2023-10-26
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer
Albert Einstein College of Medicine
Phase 2 Terminated
NCT00411138 2023-10-11
PORTEC-3
Leiden University Medical Center
Phase 3 Unknown
NCT05406856 2023-10-11
PROTECT
Leiden University Medical Center
Phase NA Recruiting
NCT01367301 2023-08-21
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
Albert Einstein College of Medicine
Phase NA Terminated
NCT05879796 2023-05-30
Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer
Peking University Third Hospital
Not yet recruiting
NCT04336683 2023-05-17
Feasibility Study for Ultrasound-Guided Interstitial Brachytherapy for Gynecological CancersV2
Western University, Canada
Phase NA Completed
NCT05799469 2023-04-05
Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer
Chongqing University Cancer Hospital
Phase 2 Not yet recruiting
NCT00492778 2023-03-29
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
GOG Foundation
Phase 2 Unknown
NCT05772377 2023-03-16
Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT01399658 2023-03-14
AMIGO
Dana-Farber Cancer Institute
Phase 2 Completed
NCT05210270 2023-01-31
HYACINCT
University of Santo Tomas Hospital, Philippines
Phase 1/2 Not yet recruiting
NCT01414608 2022-11-07
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
GOG Foundation
Phase 3 Completed
NCT04772001 2022-05-18
Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer
Zhongnan Hospital
Phase NA Unknown
NCT00376844 2022-04-12
PORTEC-2
Leiden University Medical Center
Phase 3 Completed
NCT03956498 2022-03-24
FEMINICOL
Institut Claudius Regaud
Phase NA Completed
NCT03955367 2022-02-23
Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer
Peking Union Medical College Hospital
Phase 3 Unknown
NCT05242861 2022-02-16
RetroBT
Zhejiang Cancer Hospital
Recruiting
NCT05105672 2021-12-28
A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase 2 Unknown
NCT00942357 2021-10-19
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
GOG Foundation
Phase 3 Unknown
NCT04767425 2021-02-23
Image Guided Brachytherapy in Locally Advanced Cancer Cervix
Sohag University
Phase NA Unknown